Harrow, Inc. Property, Plant and Equipment, Gross
Harrow, Inc. (HROW) had Property, Plant and Equipment, Gross of $15.48 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-02
- 2025-12-31: Property, Plant and Equipment, Gross $15.48M.
- 2025-09-30: Property, Plant and Equipment, Gross $15.38M.
- 2025-06-30: Property, Plant and Equipment, Gross $15.17M.
- 2025-03-31: Property, Plant and Equipment, Gross $14.89M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $15.48M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $15.38M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $15.17M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $14.89M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $14.75M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $14.64M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $13.96M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $13.76M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $13.59M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $13.43M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $13.15M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $12.87M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $12.55M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $12.15M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $11.38M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $11.18M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $10.97M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $12.92M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $12.63M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $11.48M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $10.25M 10-K · filed 2022-03-10 | $11.27M 10-K · filed 2021-03-08 |
| 2020-09-30 | $11.55M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $11.30M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $10.99M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $10.77M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $10.16M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $11.19M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $11.00M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $10.74M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $10.04M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $9.52M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $9.16M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $8.97M 10-K · filed 2019-03-12 | |
| 2016-12-31 | $8.65M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $2.96M 10-K · filed 2017-03-21 | |
| 2014-12-31 | $288.00K 10-K · filed 2016-03-23 | $288.83K 10-K · filed 2015-03-12 |
| 2013-12-31 | $34.98K 10-K · filed 2015-03-12 | |
| 2012-12-31 | $15.49K 10-K · filed 2013-03-18 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |